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Numerous reports have illustrated the versatility of polychlorinated biphenyls (PCBs) and related hal-
ogenated aromatics as inducers of drug-metabolizing enzymes and the activity of individual compounds
are remarkably dependent on structure. The most active PCB congeners, 3,4,4',5-tetra-, 3,3',4,4'-tetra-,
3,3',4,4',5-penta- and 3,3',4,4',5,5'-hexachlorobiphenyl, are substituted at both para and at two or more
meta positions. The four coplanar PCBs resembled 3-methylcholanthrene (3-MC) and 2,3,7,8-tetrachlo-
rodibenzo-p-dioxin (2,3,7,8-TCDD) in their mode of induction of the hepatic drug-metabolizing enzymes.
These compounds induced rat hepatic microsomal benzo(a)pyrene hydroxylase (aryl hydrocarbon hy-
droxylase, AHH) andcytochromes P-450a, P-450c and P-450d. 3,4,4',5-Tetrachlorobiphenyl, the least active
coplanar PCB, also induced dimethylaminoantipyrine N-demethylase and cytochromes P-450b+e and
resembled Aroclor 1254 as an inducer of the mixed-function oxidase system. Like Aroclor 1254, all the
mono-ortho- and at least eight di-ortho-chloro analogs of the coplanar PCBs exhibited a "mixed-type"
induction pattern and induced microsomal AHH, dimethylaminoantipyrine NM-demethylase and cyto-
chromes P-450a-P-450e. Quantative structure-activity relationships (QSARs) within this series of PCBs
were determined by comparing their AHH induction potencies (EC.4) in rat hepatoma H-4-II-E cells and
their binding affinities (ED50) for the 2,3,7,8-TCDD cytosolic receptor protein. The results showed that
there was an excellent correlation between AHH induction potencies and receptor binding avidities of
these compounds and the order of activity was coplanar PCBs (3,3',4,4'-tetra-, 3,3',4,4',5-penta- and
3,3',4,4',5,5'-hexachlorobiphenyls) > 3,4,4',5-tetrachlorobiphenyl - mono-ortho coplanar PCBs > di-ortho
coplanar PCBs. It was also apparent that the relative toxicities of this group of PCBs paralleled their
biological potencies.
The coplanar and mono-ortho coplanar PCBs also exhibit differential effects in the inbred C57BL/6J
and DBA/2J mice. These compounds induce AHH and cause thymic atrophy in the former "responsive"
mice whereas at comparable or higher doses none ofthese effects are observed in the nonresponsive DBD/
2J mice. Since the responsiveness of these two mice strains is due to the presence of the Ah receptor
protein in the C57BL/6J mice and its relatively low concentration in the DBA/2J mice, the results for the
PCB cogeners support the proposed receptor-mediated mechanism of action.
Although the precise structural requirements forligandbindingtothereceptorhave notbeendelineated,
thehalogenated aromatic hydrocarbons which exhibitthehighestbindingaffinitiesforthereceptorprotein
are approximate isostereomers of 2,3,7,8-TCDD. 2,3,4,4',5-Pentachlorobiphenyl elicits effects which are
qualitatively similar to that of TCDD and the presence of the lateral 4'-substituent is required for this
activity. Thus the 4'-substituted 2,3,4,5-tetrachlorobiphenyls have been used as probes fordetermining the
substituent characteristics which favor binding to the receptor protein. Multiple regression analysis of
the competitive binding EC50 values for 13 substituents gave the following equation: log (1/EC5O) = 1.53a
+ 1.47T + 1.09 HB + 4.08 where a is electronegativity, a is hydrophobicity, HB is hydrogen bonding and
r is the correlation coefficient (r = 0.978). The utility of this equation in describing ligand:receptor
interactions and correlations with toxicity are being studied with other halogenated hydrocarbons and
PAHs.
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porphyria and related liver damage. In PCB-exposed
animals, these effects are preceded by the induction of
numerous enzymes including the hapatic and extrahe-
patic drug-metabolizing enzymes.
Inducers of this latter enzyme system have tradi-
tionally been divided into two main classes, typified by
phenobarbital (PB) and 3-methylcholanthrene (3-MC)
(16-18). Pretreatment of rats with PB-type inducers
enhances numerous hepatic drug-metabolizing enzyme
activities including several cytochrome P-450-depen-
dent monooxygenases (e.g., dimethylaminoantipyrine
(DMAP), ethylmorphine and related N-dealkylases, bi-
phenyl-4-hydroxylase, aldrin epoxidase and several 0-
dealkylases). Incontrast, 3-MC and3-MC-typeinducers
enhance hepatic microsomal benzo(a)pyrene hydroxyl-
ase, ethoxyresorufin 0-deethylase (EROD) and several
other cytochrome P-450-dependent monooxygenases.
The differential effects of3-MC, PB and other monoox-
ygenase enzyme inducers are directly related to their
induction ofspecificcytochrome P-450isozymes(19-23).
3-MC and related compounds induce cytochromes P-
450a, P-450c and P-450d, whereas PB and PB-type
chemicals induce cytochromes P-450a, P-450b plus P-
450e (21). Aroclor 1254 induces both the PB- and 3-MC
inducible monooxygenases (24-26) and cytochromes P-
450a-P-450e (21,27-31) and resemble PB plus 3-MC
(coadministered) in its mode of drug-metabolizing en-
zyme induction. In retrospect, this bifunctional or
"mixed-type" induction patternforAroclor 1254wasnot
unexpected since the commercial PCB formulations are
complex mixtures ofisomers and congeners which con-
tribute to the observed induction activity (1,32-34).
The mechanism ofaction ofthe toxic halogenated ar-
omatics has primarily been derived byinvestigating the
effects of2,3,7,8-TCDD and related PCDD isomers and
congeners and several highly toxic halogenated aro-
matics that are approximate isostereomers of 2,3,7,8-
TCDD (11,12,35-38). Several significant correlations
were noted for the PCDD series ofcompounds, includ-
ing: (1) the most active PCDDs are substituted at the
2,3,7, and 8 lateral positions (i.e., 2,3,7,8-TCDD), and
Cl substitution orremoval ofthe lateral Clgroups gives
compounds with diminished activity; (2) there is an ex-
cellent correlation between the toxicity of several
PCDDs, their AHH-inducingpotency and theirrelative
affinities for a high affinity, low capacity hepatic cyto-
solic receptor protein; (3) the differential effects of the
PCDDs and related toxic halogenated aromatics on ge-
netically inbred nonresponsive DBA/2J and responsive
C57BL/6J mice suggest that receptor protein binding
by these toxic ligands is the first critical step which
initiates the complex sequence of events leading to the
observed biologic and toxic responses. In C57BL/6J mice
the soluble binding protein (i.e., the Ah receptor) also
plays a role in mediating the activities of several aro-
matic hydrocarbons such as 3-MC and benzo(a)pyrene.
The most toxic PCB congeners, namely, 3,3',4,4'-
tetra-, 3,3',4,4',5-penta- and 3,3',4,4',5,5'-hexachloro-
biphenyl can assume coplanar conformations and are
approximate isostereomers of 2,3,7,8-TCDD. These
three PCBs are potent AHH inducers (39-43), elicit
biologic and toxic effects comparable to those reported
for 2,3,7,8-TCDD, and the results support a common
mechanism of action for the toxic PCBs and PCDDs.
Based on PCB structure-activity relationships (SARs),
it was concluded that the most active compounds must
be substituted attheparaand atleast one metaposition
of both phenyl rings and must not contain any ortho-
chloro substituents (40,41). Unfortunately, the pro-
posed PCB SARs define a subset of three compounds
that are highly active but are present as only trace
components in the commercial PCB mixtures (44). It is
conceivable that the observed biologic and toxic effects
of PCB formulations may either be due to the trace
levels ofthe coplanarPCBs, and/orthe presence ofhighly
toxic PCDF impurities (45,46) or the presence ofother
toxicPCBswhichhave notbeendefinedbytheproposed
structure-activity correlations (40,41). Studies in our
laboratory with Aroclor 1254 showed that after Florisil
column chromatography, the cleaned-up (PCDF-free)
commercialPCBs and the crude mixture exhibited com-
parable AHH induction potencies. This suggested that
unidentified toxic PCBs may be present in the com-
mercialmixtures and amore comprehensive PCB struc-
ture-activity study was undertaken to resolve this
problem.
Coplanar PCBs
A systematic study ofthe effects of structure on the
AHH-inducing activity ofPCBs would require the syn-
thesis ofall209isomers and congeners. However, struc-
tural considerations dictate that only PCBs which are
substituted in the para and meta positions will exhibit
maximum coplanar conformational character and ap-
proximate therelativelyflat structure of2,3,7,8-TCDD.
Moreover, of the 20 possible coplanar PCBs, it is ap-
parent from several studies thatAHH-inducingactivity
isonlyobservedforcompounds substituted atbothpara
positions (40,41,47). Figure 1 thus summarizes the
structures of all the 4,4'-dichlorobiphenyl-substituted
PCBs and represents a subset ofthe group ofcoplanar
compounds that are most likely to exhibit activity. Sev-
eral reports have shown that 4,4'-dichlorobiphenyl re-
sembles PB in its mode ofenzyme induction (40,41,48,49);
the stepwise introduction of meta-chloro substituents
into this base 4,4'-dichlorobiphenyl molecule has sig-
nificant effects on the biologic and toxic effects of the
resultant PCBs. 3,4,4'-Tri- and 3,4,4',5-tetrachlorobi-
phenyl exhibit mixed-type induction activity in male
Long-Evans and Wistar rats, and this is characterized
by the induction of hepatic microsomal AHH, DMAP
N-demethylase and cytochromes P-450a- P-450e
(47,50,51). In contrast the 3,3',4,4'-tetra-, 3,3',4,4',5-
penta- and 3,3',4,4',5,5'-hexachlorobiphenyls are more
selective in their enzyme induction activity and induce
microsomal AHH and cytochromes P-450a, P-450c and
P-450d. A semiquantitative comparison of the activity
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of the coplanar PCBs is apparent from their potencies
as inducers of cytochromes P-450c plus P-450d; the or-
der of increasing inducing activity was 3,4,4'-tri- <
3,4,4',5-tetra- < 3,3',4,4'-tetra- < 3,3',4,4',5-penta <
3,3',4,4',5,5'-hexachlorobiphenyl (Table 1). The quan-
titative SAR within this group of coplanar PCBs was
determined by measuring their AHH/EROD induction
potencies with rat hepatoma H-4-II-E cell in culture
and their relative binding affinities for the male Wistar
rats hepatic cytosolic receptorprotein (51,52). The EC50
and values for enzyme induction were estimated from
dose-response studies; the ED50 for binding affinities
were derived from the effects of different concentra-
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FIGURE 1. Structures ofallthe coplanar PCB congeners substituted
at both para and 0-4 meta positions.
tionsofeachPCB congenerindisplacing(competitively)
bound [3H]TCDD from the receptor protein. Figure 2
summarizes the results of these studies and illustrates
the excellent correlation between AHH induction po-
tencies and receptor binding affinities for this group of
coplanar PCBs.
Several studies reported the toxic effects ofthe 4,4'-
dichlorobiphenyl-substituted coplanar PCBs and these
data confirm the correlation between the in vitro AHH/
EROD induction and receptor binding activities and
toxicity (39,40,53,54). 4,4'-Dichlorobiphenyl is rela-
tively nontoxic and does not induce AHH; 3,4,4'-trich-
lorobiphenyl, the least active AHH inducer within this
group ofcoplanar PCBs, does not cause thymic atrophy
in male Long-Evans rats at a dose of 500 ,umole/kg; in
contrast, pretreatment with the same dose level ofthe
3,4,4',5-tetra-, 3,3',4,4'-tetra-, 3,3',4,4',5-penta and
3,31'4,4',5,5'-hexachlorobiphenyls resulted in signifi-
cantly reduced thymus weights in the Long-Evans rats
(50). Several additional papers clearly show that the
more active 3,3',4,4'-tetra-, 3,3',4,4',5-penta- and
3,3',4,4',5,5'-hexachlorobiphenyls elicit toxic responses
typical of2,3,7,8-TCDD including weight loss after ex-
posure, hepatonecrosis, porphyria, thymic atrophy and
reproductive toxicity (38,41,50,53-55).
Mono-ortho Coplanar PCBs
The introduction of a single ortho-chloro substituent
into the biphenyl ring results in decreased coplanarity
between the two phenyl rings due to steric interactions
between the bulky ortho-chloro and hydrogen substi-
tuents. It was initally assumed (40,41) that the reduc-
tion in coplanarity for these compounds would prevent
theirbindingtothecytosolicreceptorandthuseliminate
Tble 1. PCBs: Summary of structure-function relationships.
Cytochromes P-450
induction, % of controla Relative activity
P-450c P-450b AHH induction, % Receptor
PCB structures + + binding,
(n) P-450d P-450e In vivob In vitroc %
Coplanar PCBs-If 4100-1800 No + + + 100-1 100-35
(3) induction
Coplanar PCBs-II9 1500-1100 1400-600 + + 3 x 10-2h 0.5h
(2)
Mono-ortho coplanars 2400-750 4700-2600 + + 0.3 - 2.4 x 107 6-1.5
(8)
Di-ortho coplanars 900-250 6300-1000 + Inactive < 0.3e
(12)
2,2',4,4',5,5'-Hexa- No 7300 Inactive Inactive < 0.3
chlorobiphenyl induction
2,3,7,8-TCDD 3500 No + + + + + 400 2500
induction
aMale Long-Evans rats (dose: 500 mole/kg).
bMale Wistar rats (dose: 300 mole/kg).
cRat hepatoma H-4-II-E cells.
dDetermined by the competitive displacement of [3H] TCDD bound to male Wistar rat hepatic cytosol.
eRepresents nonspecific binding.
f3,3',4,4'-Ttra-, 3,3',4,4',5-penta- and 3,3',4,4',5,5'-hexachlorobiphenyl.
93,4,4'-Tri- and 3,4,4',5-tetrachlorobiphenyl.
hDetermined only for 3,4,4',5-tetrachlorobiphenyl.
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FIGURE 2. AHH/EROD induction potencies (bottom) and cytosolic receptor protein binding affinities of coplanar and mono-ortho coplanar
PCB isomers and congeners. O EROD; O AHH; Ol Ah receptor binding.
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FIGURE 3. Structures of the most active coplanar PCB congeners
(top) and the substitution patterns of their corresponding mono-
ortho analogs (bottom).
theirtoxic and biologic effects. The effects ofortho sub-
stituents on PCB activity were tested by synthesizing
all the mono-ortho analogs of the most active coplanar
PCBs (i.e., 3,4,4,5,-tetra-, 3,3,4,4-tetra-, 3,3',4,4',5-
penta- and 3,3',4,4',5,5'-hexachlorobiphenyl) (Fig. 3) and
determining the mixed-function oxidase enzyme-induc-
ing activities in immature male Wistar and Long-Evans
rats (50,56,57). Allofthese compounds induceAHH and
DMAP N-demethylase in the Wistar rats and cyto-
chromes P-450a-P-450e in the Long-Evans rats. It was
apparent that the mono-ortho analogs of the coplanar
PCBs resembled PB plus 3-MC (coadministered) and
Aroclor 1254intheirmode ofdrug-metabolizing enzyme
induction. Figure 2 illustrates the in vitro quantitative
SAR within this group of PCBs for AHH/EROD in-
ductionpotencies andreceptorbindingaffinities. A com-
parison ofthe coplanar and mono-ortho coplanar PCBs
clearly shows that the ortho-chloro substituent dimin-
ishes but does not eliminate binding affinities of the
mono-ortho coplanar PCBs are accompanied by de-
creased AHH/EROD induction potencies. These results
identify the structures ofthe active chlorinated biphen-
yls components in the commercial PCB. Several mono-
ortho coplanar PCBs, including 2,3,3',4,4'-penta-,
2,3',4,4',5-penta-, 2,3,3',4,4',5-hexa- and 2,3,3',4,4',5,5'-
heptachlorobiphenyl have been identified in several
commercial formulations including the Aroclors, Phen-
oclors and Kanechlors (1,32-34).
The toxicities ofthe mono-ortho coplanar PCBs have
not been systematically investigated; however, many of
these compounds elicit toxic effects similar to 2,3,7,8-
TCDDandrelatedhalogenatedaromatics. Forexample:
2,3',4,',5-penta-, 2,3,3',4,4'-penta-, 2,3,3',4,4',5-hexa-
and 2,3,3',4,4',5'-hexachlorobiphenyl cause thymic
atrophy in rats (50). Administration of2,3,3',4,4' -pen-
tachlorobiphenyl to mice and rats results in a wasting
syndrome (weight loss), edema, liver lipid accumula-
tion, extensive hepaticdamage and splenicatrophy (58);
2,3',4,4',5-pentachlorobiphenyl causes 100% embryo
mortalityin eggsfrompulletsreceivingthePCB intheir
diet at a level of20 ppm (59); administration of2,2',4,4',5-
penta- and 2,3,3',4,4',5-hexachlorobiphenyl to rats
caused increased liver weights, increased liver lipids
and thymic atrophy (60). These data indicate that at
least five ofthe mono-ortho analogs ofthe coplanar PCBs
elicit toxic effects which resemble (qualitatively) 2,3,7,8-
TCDD, and several of these compounds (2,3,3',4,4'-
penta, 2,3',4,4',5-penta-, 2,3,3',4,4',5-hexachlorobi-
phenyl) have been identified in commercial PCBs and
asresidues inhumantissues (32,61,62). Futureresearch
should establish the quantitative contributions of this
group of compounds to the toxic and biologic effect of
commercial PCBs and the PCB residues which persist
in human tissues.
0 m
0
0
CO
2
'-
o
2
A
0 ww
S 2
lU a
Q0
8 -
6-
4 -
2 -
50STRUCTURE-FUNCTION RELATIONSHIPS
Di-ortho Coplanar PCBs
The steric interactions of two-ortho-chloro substi-
tuents would markedly inhibit biphenylringcoplanarity
and presumably decrease binding to the cytosolic re-
ceptor protein. Thus the di-ortho-substituted PCBs
should not be inducers ofAHH (or cytochromes P-450c
and P450d) or elicit the toxic responses typical of2,3,7,8-
TCDD. However, these conclusions did not correlate
with several conflicting reports in the literature which
indicated that thre di-ortho coplanar PCBs, namely
2,2',3,3',4,4'-, 2,2',3,4,4',5'- and 2,2',4,4',5,5'-hexach-
loro biphenyl, either induced microsomal AHH or re-
sembled PB in their mode of induction (40,41,63-65).
The problem was partially resolved when 2,3,7,8-te-
trachlorodibenzofuran, a contaminant formed in the
synthesis of 2,2',4,4',5,5'-hexachlorobiphenyl, was
shown to be the active AHH-inducing component ofthe
commercially available isomeric hexachlorobiphenyl
(065). Since several di-ortho-substituted PCBs, includ-
ing2,2',4,4',5,5'- and2,2',3,4,4',5'-hexachlorobiphenyl,
are major components ofthe commercial mixtures (32-
34), the microsomal mixed-function oxidase enzyme in-
duction activities of all the di-ortho coplanar PCBs an-
alogs were determined (Fig. 4). The results (66,67)
indicated that in male Wistar rats (dose level: 300 ,umole/
kg) at least five members of this group, namely
2,2',3,3',4,4'-hexa, 2,3,3',4,4',6-hexa-, 2,2',3,4,4',5'-
hexa, 2,3,4,4',5,6-hexa- and 2,2',3,3',4,4',5-heptachlo-
robiphenyl, exhibited a mixed-type induction pattern.
Using the more sensitive cytochrome P-450 isozyme im-
munoquantitation assay, it was shown that these five
PCBs and at least two additional compounds, 2,3',4,4',6-
penta and 2,3',4,4',5',6-hexachlorobiphenyl, induced
cytochromes P-450a-P-450e in male Long-Evans rats
(dose level: 500 ,umole/kg) (50). Since not all the di-ortho
coplanar PCBs were evaluated as inducers of cyto-
chrome P-450c, the isozyme associated with AHH in-
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FIGURE 4. Structures of the most active coplanar PCB congeners
(top) and the substitution patterns oftheir corresponding di-ortho
analogs (bottom).
duction, it is possible that other members ofthis group
may also induce this hemoprotein. 2,2',4,4',5,5'-Hex-
achlorobiphenyl was the only di-ortho coplanar PCB that
did not induce cytochromes P-450c and P-450d but, like
PB, induced cytochromes P-450a and P-450b + P-450e
(50).
The di-ortho coplanar PCBs exhibited low binding
affinities forthe cytosolicreceptorprotein (52) and were
relatively inactive as AHH/EROD inducers in rat hep-
atoma H-4-II-E cells (51). Thus, no meaningful quan-
titative SAR were derived for these compounds.
The toxicity of the di-ortho coplanar PCBs has not
been systematically investigated; however, two mem-
bers ofthis group, 2,2',3,3',4,4'- and 2,2',3,4,4',5'-hex-
achlorobiphenyl are porphyrinogenic in rats after long-
term feeding studies (64). Both ofthese compounds are
among the most active di-ortho coplanar PCB inducers
of rat hepatic microsomal AHH and cytochromes P-
450c. Based on the relatively low activities ofthis group
of compounds, future toxicologic research should focus
on the effects of2,2',3,4,4',5'-hexachlorobiphenyl since
this isomer is a major component of commercial PCBs
and preferentially bioconcentrates in human blood, adi-
pose tissue and breast milk (32-34,61,62).
Differential Effects on Genetically
Inbred C57BL/6J and DBA/2J Mice
This paper has focused on the remarkable effects of
structure on the biologic and toxic potencies of PCBs
and the parallel between the effects of PCBs and the
related toxic halogenated aromatics. It is evident that
for both PCBs and PCDDs the most active compounds
are approximae isostereomers of2,3,7,8-TCDD and there
is an excellent correlation between the cytosolic recep-
torbinding affinities, AHH induction potencies and tox-
icities ofthesehalogenated aromatics. Furtherevidence
for a common mechanism ofaction ofPCBs and PCDDs
is suggested by the differential effects of these com-
pounds on the responsive C57BL/6J and nonresponsive
DBA/2J inbred mice (38,40,42,68-70). Administration
of the coplanar PCBs or 2,3,7,8-TCDD to C57BL/6J
mice results in the induction ofhepatic microsomal AHH,
immunotoxicity and weight loss whereas the nonres-
ponsive mice are much less susceptible to the effects of
these compounds (e.g., Fig. 5). 2,3,4,4',5-Pentachlo-
robiphenyl, a mono-ortho coplanar PCB induces AHH
and causes thymic atrophy in the responsive C57BL/6J
mice whereas no significant AHH induction or thymic
atrophy is observed in the DBA/2J mice (62). Compa-
rable results have been obtained for most ofthe mono-
ortho coplanar PCBs (70) and Aroclor 1254 and this
suggests that this group of compounds and their co-
planar PCB precursors all act through a common mech-
anism. Support for the receptor-mediated mechanism
of action of 2,3,7,8-TCDD has been derived from com-
parable studies with the two inbred mice strains (36-
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38). The responsive C57BL/6J mice contain relatively
high levels of the Ah receptor in hepatic and extrahe-
patictissueswhereasrelativelylowlevelsofthisprotein
have been detected in the nonresponsive DBA/2J mice
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FIGURE 5. Benzo(a)pyrene hydroxylase induction in C57BL/6J and
DBA/2J mice by corn oil, 3-MC, 3,3',4,4'-tetrachlorobiphenyl,
2,3,4,4',5-pentachlorobiphenyl and Aroclor 1254.
(71). Therefore the differential effects of coplanar and
mono-ortho coplanar PCB congeners in the two strains
of mice lend further support to the proposed receptor-
mediatedmechanismsofactionforthetoxichalogenated
aromatics.
Receptor: Ligand Interactions:
QSAR
The qualitative and quantitative SARs observed for
PCB isomers and congeners also support the proposed
mechanism ofactionforthe toxichalogenated aromatics
(Fig. 6). This model is based on the mechanism ofaction
ofsteroid hormones in which the process is initiated by
the noncovalent interaction between a ligand (i.e., a
coplanartoxichalogromatic) and areceptorprotein. The
ligand: receptor binding complex is then translocated
into the nucleus, and presumably interacts with a spe-
cific region of the nuclear DNA. These events trigger
the de novo synthesis ofm-RNA and protein which ul-
timately leads to the pleiotypic responses observed in
the host animals. Although there is considerable evi-
dence for a receptor-mediated mechanism of action for
PCBs, the mechanistic details for the individual steps
involvedinthisprocessarenotwelldefined. Thisreview
has focused on two aspects of this model, namely, the
receptor:ligand interaction and the induction of cyto-
chrome P-450-dependent monooxygenases.
McKinney and co-workers (72,73) have suggested that
animportant factorwhich facilitates the ligand:receptor
protein interaction is the molecular polarizability ofthe
lateral chloro substituents. A more comprehensive un-
derstanding of ligand:receptor interactions can be ob-
tained by determining quantitative SARs within a series
of structurally related compounds (74-77). This ap-
proach is routinely used in planning the synthesis of
new agricultural chemicals and drugs and requires an
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active model chemical substrate that is amenable to
structural manipulation at an active site. We have cho-
sen 4'-substituted 2,3,4,5-tetrachlorobiphenyls (Fig. 7)
as our first group ofstructurally related ligands for the
following reasons (78,79): (1) 4'-substituted-2,3,4,5-te-
trachlorobiphenyls contain a single variable substituent
located atacriticallateral (para) position inthebiphenyl
nucleus, and the unsubstituted compound (Fig. 7, X =
H) is relatively nontoxic and does not induce hepatic
microsomal AHH; (2) like other toxic halogenated ar-
omatics, the parent PCB congener, 2,3,4,4',5-pentach-
lorobiphenyl, induces microsomal AHH and cytochromes
P-450c and P-450d, binds to the hepatic cytosolic re-
ceptor protein and causes thymic atrophy and weight
loss in male Wistar rats; 2,3,4,4',5-pentachlorobiphenyl
elicits similar effects in the responsive C57BL/6J mice
but is inactive in the nonresponsive DBA/2J mice (Fig.
5); (3) this series of compounds can be synthesized by
the Cadogan coupling of 4-substituted anilines and
1,2,3,4-tetrachlorobenzene togive asingle biphenyl cou-
pling product.
Figure 7 illustrates the structurally diverse 4'-sub-
stituted-2,3,4,5-tetrachlorobiphenyls which were used
as ligands for the competitive receptor binding assays.
The results obtained for 13 different halogenated bi-
phenyls that differ only in the structure ofthe 4'-lateral
substituent is summarized in Figure 8. Multiple linear
regression analysis were performed with a FACOM
M200 computer at the Data Processing Center ofKyoto
University. Hydrophobic (,n), electronic (5) and hydro-
gen-binding (HB) accepting parameters were assigned
for each substituent.
Hammett constants for the substituents were ob-
tained from the literature (75) and values were calcu-
lated as described (77). The HB parameters for each
substituent were assigned values of zero (for nonhy-
drogen bonders) or one (for hydrogen bonders) (76).
Preliminary analysis of the receptor binding data indi-
cated that three compounds with bulky 4'-substituents
(X =phenyl, n-butylandt-butyl)didnotfittheequation.
One apparent reason for their lack of fit is the van der
Waals volume ofthe bulky substituents (> 35 cm/mole
for these groups) which introduces a steric factor into
the calculation. Ifthe results for the bulky 4'-n-butyl-,
4'-t-butyl and 4'-phenyl-2,3,4,5-tetrachlorobiphenyls are
omitted, thus multiple regression analysis of the data
gave
log (1/EC.) = 139 u + 1.31 ar + 1.2 HB + 4.20
for n = 15, SD = 0.31, r = 0.916, where r is the
correlation coefficient and SD the standard deviation.
This equation was recalculated by omittingthe receptor
binding time for the 4'-nitro- and 4'-N-acetylamino-
2,3,4,5-tetrachlorobiphenyls. The latter compound did
not fit the equation and there were problems in assign-
ing an HB value for the nitro-substituted biphenyl due
to possible in-plane and out-of-plane conformations. The
recalculated equation for 13 compounds was
log (1/EC50) = 1.53 uF + 1.47 -r + 1.09 HB + 4.08
for n = 13, SD = 0.13, r = 0.978. The excellent cor-
relation between binding affinities and substituent
physical chemical parameters thus confirms the impor-
tance of steric, electronic, hydrophobic and hydrogen
bonding factors in facilitating the interactions between
toxic haloaromatics and the active binding state of the
cytosolic receptor protein. The validity of the QSAR
approach has been confirmed by determining the AHH/
EROD induction potencies ofthe 4'-substituted-2,3,4,5-
tetrachlorobiphenyls using rat hepatoma H-4-II-E cells
in culture. With one exception, the order of induction
potencyforthesecompoundswasidenticaltotheirorder
of binding affinities; the linear regression equation for
this correlation is being calculated. 4'-Iso propyl-2,3,4,5-
tetrachlorobiphenyl was much less active as an inducer
than predicted from receptor binding data and this may
be related to problems in cell uptake.
Preliminary results have shown that other substi-
tuted biphenyls, dibenzo-p-dioxins and dibenzofurans
can also be used to probe in vitro QSARs and this data
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willbe used tofurtherdefine the important interactions
between halogenated aromatics and the 2,3,7,8-TCDD
receptorprotein. Itis alsoapparentfrominvivostudies
that halogenated aromatics designed for in vitro QSAR
studies can be used to investigate regulatory mecha-
nisms for cytochrome P-450 isozymes and other drug-
metabolizingenzymes. Thisresearchisnowinprogress.
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